Literature DB >> 30136907

An overview of properties of Amphora (Acidform) contraceptive vaginal gel.

Anita L Nelson1.   

Abstract

INTRODUCTION: Although only a minority of contracepting women rely solely on spermicides, they may soon be the only ongoing female method available without a prescription in the United States. Spermicides are also combined with other methods for additional pregnancy protection and/or lubrication. Nonoxynol-9 (N-9), the active ingredient in most spermicides, is cytotoxic and may increase risk of transmission of HIV and other sexually transmitted infections, especially in high-risk women. Amphora (previously called Acidform) is a noncytotoxic spermicide composed of a series of generally regarded as safe compounds, which maintains the acidity of the vagina following coitus to immobilize and kill sperm. Amphora is currently Food and Drug Administration-approved as a vaginal lubricant. Amphora is currently being tested in a multicenter Phase III contraceptive trial. AREAS COVERED: This paper describes key properties of Amphora, including its acid-buffering abilities, viscosity, stability, bioadhesiveness, and tolerability. EXPERT OPINION: Amphora is a nontoxic spermicide that maintains the pH within the vagina at levels less than 5.0 for hours, which immobilizes and kills sperm as well as many sexually transmitted pathogens. If the current clinical trial demonstrates safety, efficacy, and tolerability of Amphora as a contraceptive, it would represent a viable alternative to N-9. Its potential as a microbicide warrants further investigation.

Entities:  

Keywords:  Acidform; Amphora; acid-buffering; birth control; microbicide; spermicide; vaginal contraception

Mesh:

Substances:

Year:  2018        PMID: 30136907     DOI: 10.1080/14740338.2018.1515197

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  4 in total

1.  Preclinical contraceptive development for men and women.

Authors:  Daniel S Johnston; Erwin Goldberg
Journal:  Biol Reprod       Date:  2020-08-04       Impact factor: 4.285

Review 2.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

3.  Vaginal Polyelectrolyte Layer-by-Layer Films Based on Chitosan Derivatives and Eudragit® S100 for pH Responsive Release of Tenofovir.

Authors:  Raúl Cazorla-Luna; Araceli Martín-Illana; Fernando Notario-Pérez; Luis Miguel Bedoya; Aitana Tamayo; Roberto Ruiz-Caro; Juan Rubio; María-Dolores Veiga
Journal:  Mar Drugs       Date:  2020-01-09       Impact factor: 5.118

4.  Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.

Authors:  Erica L Plummer; Catriona S Bradshaw; Michelle Doyle; Christopher K Fairley; Gerald L Murray; Deborah Bateson; Lindi Masson; Josephine Slifirski; Gilda Tachedjian; Lenka A Vodstrcil
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.